The Relationship Between Pelvic Floor Muscle Function and Hip Pain Among Women

January 23, 2026 updated by: Gali Dar, University of Haifa

This study examines the relationship between pelvic floor muscle (PFM) function and self-perception of PFM contraction with hip pain, their severity, and hip muscle strength.

In addition, it will examines the association between PFM function, and anxiety.

Study Overview

Detailed Description

This cross-sectional study will include women with symptoms of hip-related pain persisting > three months(research group), and women without hip pain (control group). A single session will include various assessments as follows: abdominal ultrasound examination to evaluate PFM function and endurance, in addition, each participant will evaluate her ability to perform correct contraction of PFM, hand-held dynamometer testing for hip rotator muscle strength, the International Consultation on Incontinence Questionnaire (ICIQ) for evaluating symptoms and impact of urinary incontinence, the International Hip Outcome Tool 12 for assessing hip function and pain, the Hospital Anxiety & Depression Scale (HADS), and a functional performance task involving the hip muscles - a single-leg squat.

Study Type

Observational

Enrollment (Actual)

51

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

    • Haifa District
      • Haifa, Haifa District, Israel, 31905
        • Haifa University, Department of PHysical Therapy

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • Adult

Accepts Healthy Volunteers

Yes

Sampling Method

Non-Probability Sample

Study Population

women with and without hip related pain

Description

Inclusion Criteria for Research Group:

  • complaints of hip related pain,
  • Visual Analog Scale (VAS) >3 for three months,
  • with one or more of the symptoms relevant to the syndrome - (1) hip or groin pain produced by a certain movement or position, stiffness and limitation of movement or clicks from the hip joint, (2) examination A positive FADIR performed by the researcher before conducting the study

Exclusion criteria:

  • the presence of additional diagnoses of the slipped capital femoral epiphysis,
  • Perthes disease,
  • avascular necrosis, and osteoarthritis-Calve-Legg,
  • neurological or Metabolism,
  • surgery/fracture in the hip joint of which the woman complains,
  • pregnancy or childbirth in the last year,
  • Treatment of the pelvic floor in the last year.

control group - health women without any pain or symptoms in the spine and lower extremities

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

Cohorts and Interventions

Group / Cohort
Intervention / Treatment
research group
women with hip-related pain
no intervention will be performed - several diagnostic assessments tools
Other Names:
  • abdominal ultrasound
control group
healthy women without hip pain
no intervention will be performed - several diagnostic assessments tools
Other Names:
  • abdominal ultrasound

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
urinary bladder displacement in millimeters
Time Frame: baseline
bladder displacement will be measured via diagnostic ultrasound using the on screen caliper tool
baseline
International Consultation on Incontinence Questionnaire
Time Frame: baseline
evaluating the frequency, severity and impact on quality of life of urinary incontinence. The score ranges from 0-21, with a higher score indicating greater severity
baseline
pelvic floor muscle function assessed as correct movement of the urinary bladder
Time Frame: baseline
upward or downward displacement of urinary bladder will be measured via diagnostic ultrasound. Upward movement is considered the correct direction describing good function of pelvic floor muscles
baseline
pelvic floor muscles endurance of contraction in seconds
Time Frame: baseline
The participant is instructed to contract pelvic floor muscle and hold the contraction as long as possible. bladder status on ultrasound is assessed. When the bladder starts to move downward from its position the examination ends. (measured in sec).
baseline

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
muscle strength
Time Frame: baseline
hip muscle abduction sill be measure via hand held dynamometer
baseline
self-reporting of fear and anxiety of hip pain regarding quality of life
Time Frame: baseline
Hospital Anxiety & Depression Scale
baseline
hip range of motion
Time Frame: baseline
range of motion will be assessed with goniometer
baseline
function assesment
Time Frame: baseline
single leg squat
baseline
hip function assessment
Time Frame: baseline
International Hip Outcome Tool 12 questionnaire. range 0-100, with a high score indicates a high quality of life
baseline

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: Gali Dar, Prof., University of Haifa

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

September 1, 2024

Primary Completion (Actual)

September 15, 2025

Study Completion (Actual)

September 15, 2025

Study Registration Dates

First Submitted

June 17, 2024

First Submitted That Met QC Criteria

June 17, 2024

First Posted (Actual)

June 24, 2024

Study Record Updates

Last Update Posted (Actual)

January 26, 2026

Last Update Submitted That Met QC Criteria

January 23, 2026

Last Verified

January 1, 2026

More Information

Terms related to this study

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

YES

IPD Plan Description

following study completion, a paper will be submitted to international professional journal

IPD Sharing Time Frame

6 months following end of study

IPD Sharing Supporting Information Type

  • STUDY_PROTOCOL
  • CSR

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

product manufactured in and exported from the U.S.

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Hip Pain Chronic

Clinical Trials on pelvic floor muscle assessment

Subscribe